This drug can target MYC-family-driven, TERT-overexpressing and ALT-phenotype neuroblastomas and it may be considered the core agent in a cocktail of drugs to treat aggressive EUH neuroblastomas. The gene discussed is GPT; the disease is neuroblastoma.